By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Acetylon Pharmaceuticals 



Boston  Massachusetts    U.S.A.
Phone: 617-435-2664 Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical

Segment
Pharmaceuticals





Company News
Acetylon Pharmaceuticals Presents Data On Synergistic Activity Of Selective HDAC6 Inhibition In Preclinical Models Of Multiple Myeloma And Mantle Cell Lymphoma At The AACR Annual Meeting 4/22/2015 8:44:05 AM
Acetylon Pharmaceuticals Announces Preclinical Anti-Cancer Activity Of Selective HDAC1/2 Inhibitors In Neuroblastoma And Acute Myeloid Leukemia 4/20/2015 1:05:32 PM
Acetylon Pharmaceuticals Presents At The Wells Fargo Celgene Partnership Forum 1/22/2015 10:55:50 AM
Acetylon Pharmaceuticals Presents Positive Preclinical Data On Selective HDAC1/2 Inhibition For The Treatment Of Sickle Cell Disease/?-Thalassemia 12/9/2014 1:48:47 PM
Acetylon Pharmaceuticals Announces Ricolinostat Continues To Demonstrate Clinically Meaningful And Durable Disease Response Rates In Phase 1b Combination Studies In Multiple Myeloma 12/9/2014 11:12:07 AM
Acetylon Pharmaceuticals Initiates Phase 2 Study Of Ricolinostat (ACY-1215) In Combination With Pomalyst® 12/4/2014 9:34:25 AM
Acetylon Pharmaceuticals’s Selective HDAC Inhibitors To Be Featured In Multiple Presentations Of Positive Clinical And Preclinical Data At The 56th American Society of Hematology Annual Meeting And Exposition 12/1/2014 2:45:37 PM
Acetylon Pharmaceuticals Reports Ricolinostat (ACY-1215) Is Active And Well-Tolerated In Ongoing Phase 1b Studies In Patients With Refractory Multiple Myeloma At The 19th Congress Of The European Hematology Association 6/13/2014 12:02:38 PM
Acetylon Pharmaceuticals Celebrates Headquarters Expansion In Boston’s Innovation District 3/20/2014 10:09:04 AM
Acetylon Pharmaceuticals Presents Data On The Potent Activity Of Ricolinostat (ACY-1215) In Preclinical Models Of Lymphoma At The American Society of Hematology Annual Meeting 12/10/2013 12:04:01 PM
1234
//-->